Literature DB >> 35427786

The Russia-Ukraine war could bring catastrophic public-health challenges beyond COVID-19.

Céleo Ramírez1, Reyna M Durón2.   

Abstract

Entities:  

Keywords:  Armed Conflicts; Biological Warfare Agents; COVID-19; Nuclear Weapons; Radiation Effects

Mesh:

Year:  2022        PMID: 35427786      PMCID: PMC9004220          DOI: 10.1016/j.ijid.2022.04.016

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   12.074


× No keyword cloud information.
Dear Editor, Dahl et al (2022) recently warned in this journal that armed conflict and human displacement by the Russia-Ukraine conflict may increase the burden of tuberculosis in Europe, but there could be more public health problems ahead. Since last 2 years, the COVID-19 pandemic has been an important catalyst for international collaboration on public health (Jit et al., 2021). This collaboration has not been error-free, especially in relation to an equitable distribution of diagnostic tests, treatments, and vaccines between high-income and low-middle-income countries (Javed & Chattu, 2020). The pandemic has been, at least temporarily, a kind of freezer of major war conflicts worldwide owing to the joint efforts to mitigate its impact. A better understanding of the virus, growing herd immunity produced by COVID-19 vaccines and/or previous infection (Randolph & Barreiro, 2020; Radbruch & Chang, 2021), and the transition to less lethal variants (Petersen et al., 2022) have coincided with the beginning of a warfare in East Europe. The immediate consequences for Ukraine and surrounding regions are COVID-19 surges, unattended chronic diseases, emerging infections and lower vaccination rates, including anti-COVID-19 vaccination. The risk of an escalation is latent and consequences are unimaginable if nuclear weapons are used. All simulators of a nuclear war conclude in the inevitable figure of millions of deaths and an incalculable number of people affected by radiation (Nuclear Princeton, 2019). We already know about the immediate- and long-term aftermath of the Chernobyl disaster and the Hiroshima and Nagasaki nuclear bombings in World War II (Douple et al., 2011). Another threat is the use of biologic and chemical weapons that disseminate biologic agents or toxins to cause harm, disease, and death of humans or animals and harm the environment (Janseen et al., 2014; Ekzayez et al., 2020). In no way can this type of warfare be local or easy to contain. The global scientific community must warn the world leaders about the abyss into which humanity can fall if consensus is not reached in a timely manner to avoid self-destruction. After the use of nuclear weapons, there will be no winners among survivors. The health systems, especially in the countries most affected by radiation, will have to deal with its short-, medium-, and long-term effects on the population. It is time that states directly or indirectly affected by the Ukraine and Russia conflict cooperate bilaterally or multilaterally to stop the ongoing war.

Declarations

Founding source

Universidad Tecnológica Centroamericana, Honduras.

Ethical approval

Not applicable

Authors’ contribution

CR and RMD developed the concept, reviewed the literature, and wrote the manuscript.

Declaration of Competing Interest

All authors declare no competing interest related to this paper.
  9 in total

1.  A long-term perspective on immunity to COVID.

Authors:  Andreas Radbruch; Hyun-Dong Chang
Journal:  Nature       Date:  2021-07       Impact factor: 49.962

Review 2.  Chemical Weapons and public health: assessing impact and responses.

Authors:  Abdulkarim Ekzayez; M Daniel Flecknoe; Louis Lillywhite; Preeti Patel; Andreas Papamichail; Hassan Elbahtimy
Journal:  J Public Health (Oxf)       Date:  2020-08-18       Impact factor: 2.341

3.  Long-term radiation-related health effects in a unique human population: lessons learned from the atomic bomb survivors of Hiroshima and Nagasaki.

Authors:  Evan B Douple; Kiyohiko Mabuchi; Harry M Cullings; Dale L Preston; Kazunori Kodama; Yukiko Shimizu; Saeko Fujiwara; Roy E Shore
Journal:  Disaster Med Public Health Prep       Date:  2011-03       Impact factor: 1.385

4.  Armed conflict and human displacement may lead to an increase in the burden of tuberculosis in Europe.

Authors:  Victor Naestholt Dahl; Simon Tiberi; Delia Goletti; Christian Wejse
Journal:  Int J Infect Dis       Date:  2022-03-29       Impact factor: 3.623

Review 5.  Herd Immunity: Understanding COVID-19.

Authors:  Haley E Randolph; Luis B Barreiro
Journal:  Immunity       Date:  2020-05-19       Impact factor: 31.745

Review 6.  Strengthening the COVID-19 pandemic response, global leadership, and international cooperation through global health diplomacy.

Authors:  Sumbal Javed; Vijay Kumar Chattu
Journal:  Health Promot Perspect       Date:  2020-11-07

7.  Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts.

Authors:  Eskild Petersen; Francine Ntoumi; David S Hui; Aisha Abubakar; Laura D Kramer; Christina Obiero; Paul Anantharajah Tambyah; Lucille Blumberg; Richard Yapi; Seif Al-Abri; Tatiana de Castro Abreu Pinto; Dorothy Yeboah-Manu; Najmul Haider; Danny Asogun; Thirumalaisamy P Velavan; Nathan Kapata; Matthew Bates; Rashid Ansumana; Chiara Montaldo; Luchenga Mucheleng'anga; John Tembo; Peter Mwaba; Cordelia M Himwaze; Muzamil Mahdi Abdel Hamid; Sayoki Mfinanga; Leonard Mboera; Tajudeen Raj; Eleni Aklillu; Francisco Veas; Sarah Edwards; Pontiano Kaleebu; Timothy D McHugh; Jeremiah Chakaya; Thomas Nyirenda; Moses Bockarie; Peter S Nyasulu; Christian Wejse; Jean-Jacques Muyembe-Tamfum; Esam I Azhar; Markus Maeurer; Jean B Nachega; Richard Kock; Giuseppe Ippolito; Alimuddin Zumla
Journal:  Int J Infect Dis       Date:  2021-12-01       Impact factor: 3.623

Review 8.  Biological warfare, bioterrorism, and biocrime.

Authors:  H J Jansen; F J Breeveld; C Stijnis; M P Grobusch
Journal:  Clin Microbiol Infect       Date:  2014-06       Impact factor: 8.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.